1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Influence of KRAS mutation on recurrence patterns in patients undergoing hepatic resection of colorectal metastases
    Meeting Abstract

    Kemeny, N. E.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Cercek, A.; Kingham, T. P.; Jarnagin, W. R.; Fong, Y. M.; DeMatteo, R. P.; Allen, P. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in esophageal (E) and gastroesophageal junction (GEJ) cancer: Response and prolonged stable disease observed in adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Janjigian, Y. Y.; Shah, M. A.; Herrera, J.; Tang, L. H.; Fuqua, L.; Capanu, M.; Ilson, D.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Intensity-modulated radiation therapy (IMRT) for anal cancer: Results from a multi-institutional retrospective cohort study
    Meeting Abstract

    Call, J. A.; Prendergast, B. M.; Jensen, L. G.; Ord, C. B.; Goodman, K. A.; Jacob, R.; Mell, L. K.; Thomas, C. R.; Jabbour, S.; Miller, R. C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A randomized phase II study of vismodegib (V), a hedgehog (HH) pathway inhibitor, combined with FOLFOX in patients (pts) with advanced gastric and gastroesophageal junction (GEJ) carcinoma: A New York Cancer Consortium led study
    Meeting Abstract

    Cohen, D. J.; Christos, P. J.; Sparano, J. A.; Kindler, H. L.; Catenacci, D. V. T.; Bekaii-Saab, T. B.; Tahiri, S.; Janjigian, Y. Y.; Gibson, M. K.; Chan, E.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Clinical and preclinical evaluation of taxane sensitivity in gastric cancer (GC): Relevance of GC histology
    Meeting Abstract

    Galletti, G.; Cleveland, K.; Matov, A.; Hayes, J. E.; Klein, R. J.; Hassane, D. C.; Nicacio, L. V.; Giannakakou, P.; Shah, M. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Gene expression profiles of rectal cancers with mutant or wild-type Kras
    Meeting Abstract

    Garcia-Aguilar, J.; Chen, Z.; Warden, C.; Avila, K.; Zhou, N.; Yuan, Y. C.; Chen, C. T.; Weiser, M. R.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A randomized single blind controlled trial of beads versus doxorubicin-eluting beads for arterial embolization of hepatocellular carcinoma (HCC)
    Meeting Abstract

    Brown, K. T.; Gonen, M.; Do, K. G.; Covey, A. M.; Getrajdman, G. I.; Zhao, B.; Sofocleous, C. T.; Johnson, K.; Beattie, C.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Assessment of macroscopic features in relation to tumor response to neoadjuvant chemoradiation therapy in rectal cancer
    Meeting Abstract

    Arrington, A. K.; Garcia-Aguilar, J.; Duldulao, M. P.; Luu, C.; Sanchez, J.; Kim, J.; Choy, K.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II trial of (177)lutetium radiolabeled anti-PSMA antibody J591 ((177)Lu-J591) for metastatic castrate-resistant prostate cancer (metCRPC): Survival update and expansion cohort with biomarkers
    Meeting Abstract

    Tagawa, S. T.; Akhtar, N. H.; Osborne, J.; Christos, P. J.; Vallabhajosula, S.; Goldsmith, S. J.; Kahn, R.; Ecker, C.; Beltran, H.; Morris, M. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (a-CGH) from percutaneous needle biopsy compared to renal mass histology
    Meeting Abstract

    Spaliviero, M.; Stratton, K. L.; Donahue, T. F.; Gowrishankar, B.; Ma, C.; Durack, J. C.; Solomon, S. B.; Houldsworth, J.; Coleman, J. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save